Article
Radiobiological Characterization of 64CuCl2 as a Simple Tool for Prostate Cancer Theranostics
11 Nov 2018
Abstract excerpt
64CuCl2 has recently been proposed as a promising agent for prostate cancer (PCa) theranostics, based on preclinical studies in cellular and animal models, and on the increasing number of human studies documenting its use for PCa diagnosis. Nevertheless, the use of 64CuCl2 raises important radiobiological questions that have yet to be addressed. In this work, using a panel of PCa cell lines in comparison with a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
